Personalized vaccine and electric fields take on brain cancer

This early-phase study tests whether adding a personalized vaccine (made from a patient's own tumor mutations) to standard care plus Tumor Treating Fields (electric fields that disrupt cancer growth) is safe and tolerable for people with newly diagnosed glioblastoma, an aggressive brain cancer. The study enrolled 13 adults whose disease was stable after initial treatment. The main goals are to check for side effects and see if the vaccine can be successfully given.